873015-04-4

Basic information

• Product Name: 8-(2-[(R)-2-(2-methoxymethyl-pyrrolidin-1-yl)-ethyl]-benzofuran-5-yl)-6,7-dihydro-5H-1,4,8a-triaza-S-indacene
• Synonyms: 8-(2-[(R)-2-(2-methoxymethyl-pyrrolidin-1-yl)-ethyl]-benzofuran-5-yl)-6,7-dihydro-5H-1,4,8a-triaza-S-indacene
• CAS NO: 873015-04-4
• Molecular Weight: 416.523
• Mol File: 873015-04-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 8-(2-[(R)-2-(2-methoxymethyl-pyrrolidin-1-yl)-ethyl]-benzofuran-5-yl)-6,7-dihydro-5H-1,4,8a-triaza-S-indacene(CAS DataBase Reference)
• NIST Chemistry Reference: 8-(2-[(R)-2-(2-methoxymethyl-pyrrolidin-1-yl)-ethyl]-benzofuran-5-yl)-6,7-dihydro-5H-1,4,8a-triaza-S-indacene(873015-04-4)
• EPA Substance Registry System: 8-(2-[(R)-2-(2-methoxymethyl-pyrrolidin-1-yl)-ethyl]-benzofuran-5-yl)-6,7-dihydro-5H-1,4,8a-triaza-S-indacene(873015-04-4)

Safety Data

• Hazardous Substances Data: 873015-04-4(Hazardous Substances Data)

Upstream product

• 873015-38-4 methanesulfonic acid 2-[5-(6,7-dihydro-5H-1,4,8a-triaza-s-indacen-8-yl)-benzo-furan-2-yl]-ethyl ester 
• 63126-47-6 (2R)-methoxymethylpyrrolidine 

Relevant articles and documents

Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders

This invention relates to compounds having pharmacological activity, to compositions containing these compounds, and to a method of treatment employing the compounds and compositions. More particularly, this invention concerns certain non-imidazole tertiary amine derivatives and their salts and solvates. These compounds have H3 histamine receptor antagonist activity. This invention also relates to pharmaceutical compositions containing these compounds and to a method of treating disorders in which histamine H3 receptor blockade is beneficial.